Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis

作者
Shiv Saidha,Judith A. Bell,Sydney Harold,José S Marcano Belisario,Emma Hawe,Qiujun Shao,Kerri Wyse,Eric M. Maiese
出处
期刊:Neurological Sciences [Springer Science+Business Media]
卷期号:44 (5): 1515-1532 被引量:29
标识
DOI:10.1007/s10072-022-06582-y
摘要

OBJECTIVE: To exp lore changes in immunoglobulin (Ig) levels for people with relapsing-multiple sclerosis (RMS) treated with ocrelizumab or ofatumumab and the relationship between Ig levels and infections. METHODS: A systematic literature review (SLR) was conducted to identify clinical trials and real-world evidence (RWE) studies on Ig levels over time and studies on associations with infections for ocrelizumab and ofatumumab for people with RMS through 10 September 2021. Searches were conducted in Embase, MEDLINE, Cochrane Library, trial registries, and recent conference abstracts. RESULTS: Of 1,580 articles identified, 30 reporting on 11 trials and 5 RWE studies were included. Ocrelizumab trials (n = 4) had 24-336 weeks of follow-up and reported decreasing Ig G (IgG) levels, while RWE (n = 5) had 52-78 weeks of follow-up and reported IgG to be stable or decrease only slightly. IgG levels were stable in ofatumumab trials (n = 5; 104-168 weeks of follow-up), but no RWE or longer-term studies were identified. No apparent association between decreased Ig levels and infections was observed during ofatumumab treatment (ASCLEPIOS I/II), while for ocrelizumab, the only data on apparent associations between decreased IgG levels and serious infection rates were for a pooled population of people with RMS or primary progressive MS. CONCLUSION: Decreasing IgG levels have been correlated with increased infection risk over time. IgG levels appeared to decrease over time in ocrelizumab trials but remained relatively stable over time in ofatumumab trials. Additional research is needed to understand differences between ocrelizumab and ofatumumab and identify people at risk of decreasing IgG levels and infection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿的应助被roy采纳,获得10
刚刚
刚刚
少国发布了新的文献求助10
刚刚
隐形曼青的应助被dididi采纳,获得10
2秒前
博丽灵梦发布了新的文献求助10
2秒前
万能图书馆的应助被ss采纳,获得10
2秒前
2秒前
2秒前
晚安的应助被EQLZ采纳,获得10
2秒前
彭于晏的应助被11223采纳,获得10
3秒前
3秒前
真实的白发布了新的文献求助10
3秒前
养咩咩完成签到,获得积分10
3秒前
4秒前
4秒前
4秒前
Lucas的应助被毕业即胜利采纳,获得10
4秒前
科目三的应助被呆萌的寻绿采纳,获得10
4秒前
SciGPT的应助被1234567采纳,获得10
4秒前
无花果的应助被哆啦哆啦采纳,获得30
4秒前
万能图书馆的应助被胡萝卜卜采纳,获得30
4秒前
5秒前
5秒前
yccsg发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
何文艺发布了新的文献求助10
6秒前
6秒前
6秒前
6秒前
靓丽藏花完成签到,获得积分10
6秒前
6秒前
666发布了新的文献求助10
7秒前
Grin发布了新的文献求助10
7秒前
sunny发布了新的文献求助10
7秒前
奔跑的应助被兴奋的万声采纳,获得10
7秒前
7秒前
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162918
求助须知:如何正确求助?哪些是违规求助? 9557210
关于积分的说明 21738626
捐赠科研通 7753447
什么是DOI,文献DOI怎么找? 3427983
关于科研通互助平台的介绍 2552768
邀请新用户注册赠送积分活动 2472619